Latest news about Mesothelioma Research and all Asbestos Lung Cancer related information.

MesotheliomaInNews.com -
is a resource for those seeking latest news about
Mesothelioma Asbestos Cancer and Attorneys

What Mesothelioma is?

Pleural mesothelioma is an increasingly common type of lung cancer brought on by exposure to asbestos. When inhaled, asbestos fibers become embedded in the pleura, or outer lining of the lungs, leaving behind scarring and lesions. These lesions and scars eventually develop into full-blown pleural mesothelioma, a deadly form of lung cancer for which there is no cure. Asbestos fibers can also settle in the abdominal region, triggering the development of peritoneal mesothelioma. This type of lung cancer is equally dangerous

---

Latest News

Rosetta Genomics Completes Acquisition Of Parkway Clinical Laboratories Inc.
Rosetta Genomics Ltd., a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Parkway Clinical Laboratories Inc., a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of ...
Read more News Source - BioresearchOnline
Publish date - 17:32:01 07/24/08

---

Sulfide mining forum brings out hundreds
Well over 225 people filled the seats and lined the aisles at the Vermilion Community College Fine Arts Theatre last Saturday for the Sulfide Mining forum sponsored by the White Iron Chain of Lakes and the Eagles Nest Lakes associations.
Read more News Source - The Timberjay
Publish date - 19:13:05 07/24/08

---

First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more News Source - Medical News Today
Publish date - 11:12:49 07/23/08

---

PolyMVA Health Club Launches the Largest Medical, Health, and Cancer Treatments Encyclopedia
Advanced Medicine and Research Information, PolyMVAHealthClub.com the primary distributor of Poly-MVA for Cancer patients, is announcing the release of a one of its kind, comprehensive Medical and Health Encyclopedia, largely focused on Cancer and Cancer Treatments.
Read more News Source - PRWeb via Yahoo! News
Publish date - 08:06:43 07/21/08

---

HOME PAGE
Sensex companies valuation halved in six months SBI, DLF, Reliance among worst hit in PE multiple erosion. BL Research Bureau For every rupee of earnings managed by BSE Sensex companies, investors are today willing to pay only half of what they paid in January 2008. ...
Read more News Source - The Hindu
Publish date - 19:53:31 07/20/08

---

First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
Rosetta Genomics, Ltd. announces today that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center , has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.
Read more News Source - PR Newswire via Yahoo! Finance
Publish date - 12:32:33 07/22/08

---

Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone ...
Alfacell Corporation today announced that a paper published in Molecular Cancer Therapeutics (2008; 7:1871-9) reports that a combination of ONCONASE and the thiazolidinedione antidiabetic drug rosiglitazone shows a promising effect for cancers with increased expression of PI3K-dependent Fra-1 expression or Survivin.
Read more News Source - PR Newswire via Yahoo! Finance
Publish date - 12:33:05 07/21/08

---

Alfacell Receives NASDAQ Non-Compliance Notification
Alfacell Corporation today announced that it received a non-compliance notice from The NASDAQ Stock Market on July 14, 2008 stating that for the last 30 consecutive business days the bid price of the company's common stock has closed below $1.00 per share, which is the minimum bid price required for continued inclusion on the NASDAQ Capital Market by Marketplace Rule 4310.
Read more News Source - PR Newswire via Yahoo! Finance
Publish date - 20:31:34 07/18/08

---

EPA Public Meeting to Discuss the Office of Solid Waste and Emergency Response (OSWER) Interim Method to Assess ...
----Asbestos Disease Awareness Organization :
Read more News Source - Business Wire via Yahoo! Finance
Publish date - 18:35:01 07/18/08

---

---